For Innovators
For Innovators

For Innovators

Why This Is the Moment to Monetize Your IP

Cultivated meat, fish, leather, and cell-agriculture are moving fast — and the technologies behind them are key to what comes next. With the right visibility and partnerships, your IP can start creating value now.

The Opportunity Ahead

  • The cultivated foods market is set to surpass $25 billion by 2030.
  • Early engagement can cut time-to-revenue by years.
  • Strategic visibility unlocks licensing, partnerships, and dealmaking.

Now Is the Time to Act

You don’t need a full business model or product line — you need:

  • Visibility in the right circles
  • Partners who understand your tech’s potential
  • A clear path to revenue

Lab Grown Technologies helps you turn IP into real-world impact.

Let’s talk

image

Featured Producers & Innovation Partners

Major companies actively scout for new technologies — from bioprocess breakthroughs to enabling platforms. Reach out to help you find the right partners to license and scale your innovations.

Biotech & Life Science

  • Merck KGaA / MilliporeSigma
    • Long track record of supplying and co-developing media, bioreactors, and IP for biomanufacturing. Active in alternative protein partnerships.
  • Thermo Fisher Scientific
    • Supplies analytics, reagents, and equipment — often partners with R&D teams on novel assays, sensors, and cell systems.
  • Lonza
    • Open to co-developing new media components and scaling solutions in cell therapy and adjacent industries.
  • Evonik Industries
    • Active in cell nutrition and biosciences; recently expanding into alt-protein and cell culture tech.
  • Ajinomoto
    • Focused on amino acids, media, and flavor components. Invests and collaborates frequently.
  • DSM Firmenich
    • Leading fermentation and bio-ingredient player, known for corporate partnerships and open innovation initiatives.
  • ….

Food & Meat Companies

  • Cargill
    • Invested in multiple cultivated meat startups. Looks for upstream and enabling tech that fits into its protein roadmap.
  • Nestlé
    • Actively exploring cultivated and hybrid proteins; has open innovation portals for ingredient, texture, and process innovation.
  • JBS
    • Acquiring and building cultivated capacity; may partner on media, scaffolds, or bioprocess efficiencies.
  • Mitsubishi Corporation
    • Not only building cultivated capability, but also known to partner with foreign IP holders for entry into Japan.
  • NH Foods
    • Developing cultivated products in-house and likely seeking improved efficiency, cost reduction, or unique formulations.
  • ….

Is Your IP Sitting on the Shelf?

Most companies leave valuable innovations untapped. Others don’t have the time, resources, or commercial focus to explore licensing or partnerships. Meanwhile, hundreds of companies are solving the same problems — in parallel.

Much of the cultivated tech industry’s innovation remains locked away, unseen and unused.
image

Our Offering - Monthly Support Packages

We help innovators find buyers, licensees, or commercial partners for their technologies. Our tiered approach is built for flexibility: from quick scans to fully supported matchmaking.

🟦 Spotlight

Understand your technology’s commercial appeal.

We explore whether your technology is ready to be pitched and to whom. Perfect for R&D teams or early-stage companies wanting to test the waters.

Includes:

  • Opportunity scan (tech + market fit)
  • Summary of promising application areas
  • List of 10–15 potential companies
  • Advice on whether to proceed to outreach

🟦🟦 Scout

Start building momentum.

We act as your external business developer. We initiate contact with relevant companies, present the opportunity, and gather market signals.

Includes everything in Signal, plus:

  • Branded 1-pager or pitch deck
  • Direct outreach to selected targets
  • Warm introductions (where available)
  • Monthly activity + signal report

🟦🟦🟦 Secure

Go all the way.

We actively manage conversations, help structure the deal, and support until the first commercial step is taken — whether it’s a license, collaboration, or sale.

Includes everything in Scout, plus:

  • Qualification and follow-up with interested parties
  • Support during calls and meetings
  • Guidance on terms, deal structure, and next steps
  • Biweekly progress calls

Curious about pricing or which package fits your needs best? Get in touch — we're happy to walk you through it.

image

Your Technology, in the Right Hands

Potential scenarios for those who choose to spotlight their technology.

🧪 Startup Scenario — Early-Stage Biotech Team

Package: Spotlight Solo (1 technology)

Company: A team of 3 scientists with a prototype for a serum-free growth media supplement

Goal: They're not yet ready to raise a round, but want early traction and visibility

Scenario:

After being featured on Lab Grown Technologies, a foodtech VC browsing the site reaches out. The team enters initial talks. Six months later, they sign an R&D collaboration with a cultivated seafood company. The startup receives:

  • €50,000 upfront
  • €250,000 in milestone payments
  • 2% royalty on commercial use

    • Total deal potential: €1.5M+ over 4 years

Cost of listing: €1,200

Outcome: Early signal validation and first funding without giving up equity.

🏥 Biomedical Company Scenario — Repurposing Platform Tech

Package: Spotlight Core (3 technologies)

Company: A mid-sized biomedical firm with a patented perfusion bioreactor system originally developed for stem cell therapy

Goal: Explore new applications and find licensing opportunities beyond their current market

Scenario:

After listing their tech with a customized profile and matchmaking support, the company is introduced to two cultivated meat producers.

One of them runs a pilot and ends up licensing the system under an exclusive field-of-use agreement.

  • €100,000 up-front licensing fee
  • 4% royalty on net sales
  • Estimated royalty income: €3M over 5–7 years

Cost of listing: €3,500

Outcome: Monetization of dormant IP and new revenue from a market they weren't targeting.

🎓 University Scenario — Technology Transfer Office

Package: Institutional Showcase (10 technologies)

Institution: A European university with dozens of patents in biofabrication and tissue engineering

Goal: Increase visibility of underutilized IP and test new ways to support commercialization

Scenario:

The university lists 10 pre-vetted technologies in a curated cluster. A cultivated leather startup reaches out about a scaffold patent and quickly signs a €30,000 evaluation license. Within 6 months, this leads to:

  • A non-exclusive commercial license with a €75,000 upfront fee
  • 1.5% royalty on net sales, projected to bring in €300,000 over 4 years
  • Joint press release that boosts visibility for the tech transfer office
  • A second company expresses interest in a related bioreactor patent

Cost of listing: €5,000

Outcome: A licensing deal, a new industrial partner, and strong validation of the university’s commercialization pipeline

Lab Grown Technologies helps you turn IP into real-world impact.

Let’s talk